| | | |
Prevalence of Streptococcus pneumoniae in conjunctival flora and association with nasopharyngeal carriage among children in a Vietnamese community | | | |
Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries | | | |
Ebola-negative neonates born to Ebola-infected mothers after monoclonal antibody therapy: a case series | Lancet Child and Adolescent Health | | |
Challenges for drug repurposing in the COVID-19 pandemic era | Frontiers in Pharmacology | | |
Remdesivir for the treatment of Covid-19 — final report | New England Journal of Medicine | | |
Effect of Enhanced Adherence Package on Early ART Uptake Among HIV-Positive Pregnant Women in Zambia: An Individual Randomized Controlled Trial | | | |
Pharmacogenetic assessment of tafenoquine efficacy in patients with Plasmodium vivax malaria | Pharmacogenetics and Genomics | | |
The Equatoguinean Malaria Vaccine Initiative: from the launching of a clinical research platform to malaria elimination planning in central West Africa | The American Journal of Tropical Medicine and Hygiene | | |
Brief communication: immunogenicity of measles vaccine when co-administered with 10-valent pneumococcal conjugate vaccine | | | |
Safety and immunogenicity of a parenteral trivalent P2-VP8 subunit rotavirus vaccine: a multisite, randomised, double-blind, placebo-controlled trial | The Lancet Infectious Diseases | | Rotavirus gastroenteritis |
Efficacy of a spatial repellent for control of malaria in Indonesia: a cluster-randomized controlled trial | The American Journal of Tropical Medicine and Hygiene | | |
Serostatus cutoff levels and fold increase to define seroresponse to recombinant
vesicular stomatitis virus – Zaire Ebola virus envelope glycoprotein vaccine: An evidence-based analysis | | | |
The China tuberculosis clinical trials consortium network: a model for international TB clinical trials capacity building | Infectious Diseases of Poverty | | |
Impact of the COVID-19 epidemic on a Pan-Asian academic oncology clinical trial | | | |
Effect of a chikungunya virus–like particle vaccine on safety and tolerability outcomes | | | |
Pregnancy outcomes among women receiving rVSVΔ-ZEBOV-GP Ebola vaccine during the Sierra Leone Trial to Introduce a Vaccine against Ebola | Emerging Infectious Diseases | | |
The design and development of a multicentric protocol to investigate the impact of adjunctive doxycycline on the management of peripheral lymphoedema caused by lymphatic filariasis and podoconiosis | | | |
A Phase 2/3 double blinded, randomized, placebo-controlled study in healthy adult participants in Vietnam to examine the safety and immunogenicity of an inactivated whole virion, alum adjuvanted, A(H5N1) influenza vaccine (IVACFLU-A/H5N1) | | | |
Safety and immunogenicity of a novel 10-valent pneumococcal conjugate vaccine candidate in adults, toddlers, and infants in The Gambia-Results of a phase 1/2 randomized, double-blinded, controlled trial | | | |
A randomized, controlled trial of Ebola virus disease therapeutics | New England Journal of Medicine | | |
Portable infrared imaging for longitudinal limb volume monitoring in patients with lymphatic filariasis | PLoS Neglected Tropical Diseases | | |
Scalable, semi-automated fluorescence reduction neutralization assay for qualitative assessment of Ebola virus-neutralizing antibodies in human clinical samples | | | |
PREVAIL I cluster vaccination study with rVSVΔG-ZEBOV-GP as part of a public health response in Liberia | The Journal of Infectious Diseases | | |
Immunogenicity and reactogenicity of ten-valent versus 13-valent pneumococcal conjugate vaccines among infants in Ho Chi Minh City, Vietnam: a randomised controlled trial | The Lancet Infectious Diseases | | |
A longitudinal study of Ebola sequelae in Liberia | New England Journal of Medicine | | |
Ebola virus disease-related stigma among survivors declined in Liberia over an 18-month, post-outbreak period: An observational cohort study | PLoS Neglected Tropical Diseases | | |
Evaluation of the effects on the QT-interval of 4 artemisinin-based combination therapies with a correction-free and heart rate-free method | | | |
Single-dose tafenoquine to prevent relapse of Plasmodium vivax malaria | New England Journal of Medicine | | |
Tafenoquine versus primaquine to prevent relapse of Plasmodium vivax malaria | New England Journal of Medicine | | |
Timing of rotavirus vaccine doses and severe rotavirus gastroenteritis among vaccinated infants in low- and middle-income countries | | | Rotavirus gastroenteritis |
A randomized trial of a new triple drug treatment for lymphatic filariasis | New England Journal of Medicine | | |
A review of strategies used to retain participants in clinical research during an infectious disease outbreak: The PREVAIL I Ebola vaccine trial experience | Contemporary Clinical Trials Communications | | |
Early Life Interventions for Childhood Growth and Development in Tanzania (ELICIT): a protocol for a randomised factorial, double-blind, placebo-controlled trial of azithromycin, nitazoxanide and nicotinamide | | | |
Utilizing nurses to staff an Ebola vaccine clinical trial in Sierra Leone during the Ebola outbreak | Journal of Infectious Diseases | | |
The Sierra Leone Trial to Introduce a Vaccine Against Ebola: An evaluation of rVSV∆G-ZEBOV-GP vaccine tolerability and safety during the West Africa Ebola outbreak | Journal of Infectious Diseases | | |
Rapid establishment of a cold chain capacity of –60°C or colder for the STRIVE Ebola vaccine trial during the Ebola outbreak in Sierra Leone | Journal of Infectious Diseases | | |
Participant retention in a randomized clinical trial in an outbreak setting: Lessons from the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE) | Journal of Infectious Diseases | | |
Operationalizing international regulatory standards in a limited-resource setting during an epidemic: The Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE) experience | Journal of Infectious Diseases | | |
Monitoring serious adverse events in the Sierra Leone Trial to Introduce a Vaccine Against Ebola | Journal of Infectious Diseases | | |
Lessons learned in clinical trial communication during an Ebola outbreak: The implementation of STRIVE | Journal of Infectious Diseases | | |
Implementing a multisite clinical trial in the midst of an Ebola outbreak: Lessons learned from the Sierra Leone Trial to Introduce a Vaccine Against Ebola | Journal of Infectious Diseases | | |
Health conditions in an adult population in Sierra Leone: Data reported from the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE) | Journal of Infectious Diseases | | |
Evaluation of different infant vaccination schedules incorporating pneumococcal vaccination (The Vietnam Pneumococcal Project): protocol of a randomised controlled trial | | | |
Clinical surveillance and evaluation of suspected Ebola cases in a vaccine trial during an Ebola epidemic: The Sierra Leone Trial to Introduce a Vaccine Against Ebola | Journal of Infectious Diseases | | |
Use of the Filovirus Animal Non-Clinical Group (FANG) Ebola virus immuno-assay requires fewer study participants to power a study than the Alpha Diagnostic International assay | Journal of Virological Methods | | |
Timing and predictors of severe rotavirus gastroenteritis among unvaccinated infants in low- and middle-income countries | Epidemiology and Infection | | Rotavirus gastroenteritis |
Pyronaridine–artesunate or dihydroartemisinin–piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial | | | |
Utility of SOFA score, management and outcomes of sepsis in Southeast Asia: a multinational multicenter prospective observational study | Journal of Intensive Care | | |
Advancing global health through development and clinical trials partnerships: a randomized, placebo-controlled, double-blind assessment of safety, tolerability, and immunogenicity of PfSPZ vaccine for malaria in healthy Equatoguinean men | The American Journal of Tropical Medicine and Hygiene | | |
Use of a novel portable three-dimensional imaging system to measure limb volume and circumference in patients with filarial lymphedema | The American Journal of Tropical Medicine and Hygiene | | |
Phase 2 placebo-controlled trial of two vaccines to prevent Ebola in Liberia | New England Journal of Medicine | | |
Cerebrospinal fluid examination in survivors of Ebola virus disease | | | |
Clinical development of a recombinant Ebola vaccine in the midst of an unprecedented epidemic | | | |
Conventional wisdom versus actual outcomes: challenges in the conduct of an Ebola vaccine trial in Liberia during the International Public Health Emergency | The American Journal of Tropical Medicine and Hygiene | | | |
Establishment of a research pharmacy to support Ebola clinical research in Liberia | Science and Practice Advances in Pharmacy Practice | | |
Causes and outcomes of sepsis in Southeast Asia: A multinational multicentre cross-sectional study | | | |
Assessment and optimization of the GeneXpert diagnostic platform for detection of Ebola virus RNA in seminal fluid | Journal of Infectious Diseases | | |
Beating the odds: successful establishment of a phase II/III clinical research trial in resource-poor Liberia during the largest-ever Ebola outbreak | Contemporary Clinical Trials Communications | | |
A randomized, controlled trial of ZMapp for Ebola virus infection | New England Journal of Medicine | | |
Antimalarial activity of KAF156 in falciparum and vivax malaria | New England Journal of Medicine | | |
Ebola surveillance — Guinea, Liberia, and Sierra Leone | Morbidity and Mortality Weekly Report (MMWR) | | |
Ebola virus persistence in semen of male survivors | Clinical Infectious Diseases | | |
Assessing clinical research capacity in Vietnam: A framework for strengthening capability for clinical trials in developing countries | | | |
Fostering collaboration on post-Ebola clinical research in Liberia | | | |
Factors associated with HIV viral load suppression on antiretroviral therapy in Vietnam | Journal of Virus Eradication | | |
Implementation of an Ebola virus disease vaccine clinical trial during the Ebola epidemic in Liberia: Design, procedures, and challenges | | | |
Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial | Lancet Infectious Diseases | | |
Factors associated with HIV RNA viral loads in ART-naïve patients: implications for treatment as prevention in concentrated epidemics | Journal of Virus Eradication | | |
Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial | Lancet Infectious Diseases | | |
TH17-mediated protection against pneumococcal carriage by a whole-cell vaccine is dependent on toll-like receptor 2 and surface lipoproteins | Clinical and Vaccine Immunology | | |
Helicase-primase inhibitor pritelivir for HSV-2 infection | New England Journal of Medicine | | |
A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients | Journal of Infectious Diseases | | |
Oseltamivir and inhaled zanamivir as influenza prophylaxis in Thai health workers: a randomized, double-blind, placebo-controlled safety trial over 16 weeks | Journal of Antimicrobial Chemotherapy | | |
Clinical validation of a point-of-care multiplexed in vitro immunoassay using monoclonal antibodies (the MSD Influenza Test) in four hospitals in Vietnam | Journal of Clinical Microbiology | | |
The utility of Aspirin in Dukes C and High Risk Dukes B Colorectal cancer–the ASCOLT study: study protocol for a randomized controlled trial | | | |
Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial | | | |
